Evidence map›Paper›PMID 38289778›Full record

ArticleJNMA; journal of the Nepal Medical Association2023

Portal Hypertension among Patients with Chronic Liver Disease Admitted to the Department of Internal Medicine of a Tertiary Care Centre.

Sabina Khadka, Ananda Aryal, Sagun Karki, Pratik Subedi, Kanchan Bogati, Sunil Baniya, Shrekshya Khadka, Kumar Roka, Asha Shahi

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JNMA; journal of the Nepal Medical Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Sabina KhadkaNepalese Army Institute of Health Sciences, Sanobharyang, Kathmandu, Nepal.
Ananda AryalAll Nepal Hospital, Samakhusi, Kathmandu, Nepal.
Sagun KarkiNepalese Army Institute of Health Sciences, Sanobharyang, Kathmandu, Nepal.
Pratik SubediNepalese Army Institute of Health Sciences, Sanobharyang, Kathmandu, Nepal.
Kanchan BogatiOxford University Clinical Research Unit, Patan Academy of Health Sciences, Lagankhel, Lalitpur, Nepal.
Sunil BaniyaOxford University Clinical Research Unit, Patan Academy of Health Sciences, Lagankhel, Lalitpur, Nepal.
Shrekshya KhadkaNepalese Army Institute of Health Sciences, Sanobharyang, Kathmandu, Nepal.
Kumar RokaDepartment of Internal Medicine, Shree Birendra Hospital, Chhauni, Kathmandu, Nepal.
Asha ShahiNaubise Health Post, Dhunibesi, Dhading, Nepal.
Nepalese Army Institute of Health Services · NPPatan Academy of Health Sciences · NPBir Hospital · NPB.P. Koirala Institute of Health Sciences · NPCivil Service Hospital · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Portal hypertension is increased pressure within the portal vein. A portal pressure gradient of more than 10 mmHg is defined as "clinically significant portal hypertension" due to manifestations such as splenomegaly, gastroesophageal varices, ascites, hepatorenal syndrome, hepatopulmonary syndrome, hepatic encephalopathy, and spontaneous bacterial peritonitis. The aim of this study was to find out the prevalence of portal hypertension among patients with chronic liver disease admitted to the Department of Internal Medicine of a tertiary care centre. Methods: A descriptive cross-sectional study was conducted among patients with chronic liver disease in the Department of Internal Medicine of a tertiary care centre from 1 January 2021 to 31 December 2022 after obtaining ethical approval from the Institutional Review Committee. Convenience sampling method was used. The point estimate was calculated at a 95% Confidence Interval. Results: Among 247 patients with chronic liver disease, the prevalence of portal hypertension was 38 (15.38%) (10.88-19.88, 95% Confidence Interval). A total of 16 (42.11%) patients were in the age group of 51-60 years and males were 36 (94.74%). Ascites as a complication were found in 4 (10.53%). Conclusions: The prevalence of portal hypertension among chronic liver disease inpatients in a tertiary care centre was found to be lower than other studies done in international settings. Keywords: inpatients; liver disease; portal hypertension; prevalence.

Indexed as

Hepatic EncephalopathyHypertension, PortalAscitesCross-Sectional StudiesHumansMaleMiddle AgedTertiary Care Centers

Identifiers

PMID38289778
PMCPMC10579770
OpenAlexW4387262442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.